BIGNOTTI, Eliana
 Distribuzione geografica
Continente #
NA - Nord America 2.793
EU - Europa 1.098
AS - Asia 467
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 2
Totale 4.369
Nazione #
US - Stati Uniti d'America 2.768
PL - Polonia 363
CN - Cina 311
UA - Ucraina 205
DE - Germania 154
IT - Italia 138
HK - Hong Kong 95
FI - Finlandia 86
GB - Regno Unito 49
IE - Irlanda 47
VN - Vietnam 24
CA - Canada 22
SE - Svezia 16
FR - Francia 15
IN - India 12
BE - Belgio 11
SG - Singapore 9
KR - Corea 4
NL - Olanda 4
TW - Taiwan 4
BG - Bulgaria 3
BR - Brasile 3
EU - Europa 3
AU - Australia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MU - Mauritius 2
MX - Messico 2
RU - Federazione Russa 2
AT - Austria 1
AZ - Azerbaigian 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
JP - Giappone 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PT - Portogallo 1
TR - Turchia 1
Totale 4.369
Città #
Fairfield 415
Warsaw 362
Woodbridge 298
Houston 212
Ashburn 206
Seattle 199
Chandler 197
Jacksonville 151
Cambridge 138
Wilmington 135
Ann Arbor 121
Dearborn 118
New York 115
Hong Kong 78
Princeton 78
Helsinki 66
Nanjing 49
Dublin 47
Brescia 42
Beijing 39
Shanghai 28
Dong Ket 24
Jinan 23
Shenyang 21
Toronto 21
Nanchang 20
Kunming 18
Milan 16
San Diego 16
Los Angeles 15
Hebei 14
Central 13
Des Moines 13
Changsha 12
Tianjin 12
Brussels 11
Monmouth Junction 11
London 10
Hangzhou 9
Jiaxing 8
Hefei 7
Leawood 7
Ningbo 7
Kilburn 6
Norwalk 6
Zhengzhou 6
Guangzhou 5
Rome 5
Cazzago San Martino 4
Lancaster 4
Lanzhou 4
Nardò 4
Pune 4
San Francisco 4
Arezzo 3
Augusta 3
North 3
San Mateo 3
Sofia 3
Taiyuan 3
Taizhou 3
Taoyuan District 3
Verona 3
Washington 3
Xian 3
Baton Rouge 2
Bishkek 2
Chengdu 2
Cheongju-si 2
Colombo 2
Exeter 2
Gunzenhausen 2
Haikou 2
Islington 2
Melbourne 2
Mexico City 2
Neustadt an der Aisch 2
Orange 2
Phoenix 2
Redwood City 2
Salerno 2
San Bruno 2
South San Francisco 2
Wuhan 2
Almaty 1
Almere Stad 1
Amsterdam 1
Auburn Hills 1
Aveiro 1
Baku 1
Baotou 1
Berlin 1
Boardman 1
Borgo San Giacomo 1
Brooklyn 1
Buccinasco 1
Cairo 1
Casalpusterlengo 1
Catania 1
Chicago 1
Totale 3.541
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 282
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 256
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 238
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 147
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 146
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 142
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 141
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 139
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 135
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 134
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 132
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 125
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 125
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 124
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 124
Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. 122
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 121
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 119
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 118
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 116
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 113
Mammaglobin B expression in human endometrial cancer 112
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 109
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 103
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 93
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 85
Claudin-7 expression in human epithelial ovarian cancer 83
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 83
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 81
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 74
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 71
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 62
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 53
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 52
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 52
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 45
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 43
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 39
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 21
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 21
Integrated mutational landscape analysis of uterine leiomyosarcomas 21
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 19
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 19
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 17
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 16
Totale 4.473
Categoria #
all - tutte 18.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.025


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019227 0 0 0 0 0 0 0 0 0 0 106 121
2019/20201.160 117 47 41 124 81 179 165 126 90 112 27 51
2020/2021775 15 72 11 84 41 79 44 82 77 149 71 50
2021/2022461 66 92 9 3 5 27 29 21 17 63 40 89
2022/2023511 78 32 26 32 50 106 8 54 69 6 29 21
2023/2024584 38 22 65 61 34 167 34 38 86 39 0 0
Totale 4.473